Compare MOV & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOV | CTKB |
|---|---|---|
| Founded | 1961 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 690.8M | 777.3M |
| IPO Year | 1996 | 2021 |
| Metric | MOV | CTKB |
|---|---|---|
| Price | $32.11 | $5.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $47.50 | $6.50 |
| AVG Volume (30 Days) | 113.7K | ★ 1.2M |
| Earning Date | 11-24-2026 | 11-04-2026 |
| Dividend Yield | ★ 4.91% | N/A |
| EPS Growth | ★ 44.44 | N/A |
| EPS | ★ 0.84 | N/A |
| Revenue | ★ $338,600,000.00 | $193,015,000.00 |
| Revenue This Year | $5.41 | $3.83 |
| Revenue Next Year | $4.47 | $6.48 |
| P/E Ratio | $38.69 | ★ N/A |
| Revenue Growth | ★ 25.73 | 17.67 |
| 52 Week Low | $18.10 | $3.31 |
| 52 Week High | $40.50 | $6.34 |
| Indicator | MOV | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 49.88 | 46.36 |
| Support Level | $30.83 | $4.10 |
| Resistance Level | $33.36 | $6.27 |
| Average True Range (ATR) | 0.80 | 0.34 |
| MACD | 0.15 | -0.05 |
| Stochastic Oscillator | 60.00 | 19.90 |
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.